https://assets.capyfin.com/instruments/678fdc13234e27009c5d5e61.png avatar
Ryan Specialty Group
🇺🇸 NYSE:RYAN
•
Dec 31, 2024

Ryan Specialty Group Q4 2024 Earnings Report

Ryan Specialty reported strong revenue growth but faced a decline in net income for Q4 2024.

Key Takeaways

Ryan Specialty Holdings reported a 24.5% year-over-year increase in revenue to $663.5 million. However, net income fell by 27.3% to $42.6 million due to higher expenses. Adjusted net income rose by 28.9% to $123.3 million, and adjusted diluted EPS increased to $0.45. The company also achieved an 11.0% organic revenue growth rate.

Revenue grew 24.5% year-over-year to $663.5 million.

Net income declined 27.3% to $42.6 million due to increased expenses.

Adjusted net income increased 28.9% to $123.3 million.

Organic revenue growth rate was 11.0% for the quarter.

Total Revenue
$664M
Previous year: $533M
+24.5%
EPS
$0.45
Previous year: $0.35
+28.6%
Organic Revenue Growth Rate
11%
Previous year: 16.5%
-33.3%
Cash and Equivalents
$540M
Previous year: $839M
-35.6%
Total Assets
$9.65B
Previous year: $7.25B
+33.2%

Ryan Specialty Group Revenue

Ryan Specialty Group EPS

Ryan Specialty Group Revenue by Segment

Forward Guidance

Ryan Specialty expects continued revenue growth in 2025, with organic revenue growth projected between 11.0% and 13.0%, and an adjusted EBITDAC margin of 32.5% to 33.5%.

Positive Outlook

  • Organic revenue growth guidance for FY25 is 11.0% - 13.0%.
  • Adjusted EBITDAC margin projected at 32.5% - 33.5%.
  • Continued expansion through M&A strategy.
  • Strong demand for specialty insurance products.
  • Operational efficiencies expected to support margin expansion.

Challenges Ahead

  • Higher operating expenses may impact profitability.
  • Interest expenses expected to remain elevated.
  • Macroeconomic uncertainties could affect growth.
  • Competitive pressures in the specialty insurance market.
  • Foreign exchange fluctuations could impact revenue.